Oxymatrine for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis

BackgroundInflammatory Bowel Disease (IBD) is a chronic, idiopathic inflammatory disorder of the intestines. Oxymatrine (OMT) is a naturally active substance found in the desiccated roots of Sophora flavescens. It possesses anti-tumor, antiviral, and anti-inflammatory properties. In recent years, it...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuan Zhao, Xiaolu Ye, Yuting Gu, Yijie Lou, Zhanyi Zhou, Yunxi Ji, Daogun Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1542953/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850143284787150848
author Xuan Zhao
Xiaolu Ye
Yuting Gu
Yijie Lou
Zhanyi Zhou
Yunxi Ji
Yunxi Ji
Daogun Xu
author_facet Xuan Zhao
Xiaolu Ye
Yuting Gu
Yijie Lou
Zhanyi Zhou
Yunxi Ji
Yunxi Ji
Daogun Xu
author_sort Xuan Zhao
collection DOAJ
description BackgroundInflammatory Bowel Disease (IBD) is a chronic, idiopathic inflammatory disorder of the intestines. Oxymatrine (OMT) is a naturally active substance found in the desiccated roots of Sophora flavescens. It possesses anti-tumor, antiviral, and anti-inflammatory properties. In recent years, its therapeutic role in IBD has gradually been discovered. This review aims to explore the impact of OMT on inflammatory bowel disease by animal models.MethodsConduct a systematic search in the PubMed, Embase, Web of Science, Cochrane, and Medline databases. Using SYRCLE’s risk of bias tool to assess the bias risk and quality of the included studies. For some data presented as figures, Web Plot Digitizer 4.2 software was used to extract it. STATA 16.0 was selected for the final meta-analysis.ResultsAfter rigorous literature screening, 12 studies were included. The data analysis results indicated that the disease activity index (DAI), histopathological score (HS), interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), nuclear factor-κB (NF-κB), and myeloperoxidase (MPO) activity in the IBD animal models significantly decreased following intervention with oxymatrine. Furthermore, OMT also extended the colon length in the animal models and improved the expression level of zonula occludens-1(ZO-1) and occludin. These results suggested that OMT may improve the condition of IBD through anti-inflammatory, antioxidative stress and protecting the intestinal barrier.ConclusionMeta-analysis suggests oxymatrine positively affects IBD animal models. This provides new insights for the clinical treatment of inflammatory bowel disease.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD42024570580, identifier [CRD42024570580].
format Article
id doaj-art-4be29152e77b48128a6f4dea9baa5cb8
institution OA Journals
issn 2296-858X
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-4be29152e77b48128a6f4dea9baa5cb82025-08-20T02:28:46ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-04-011210.3389/fmed.2025.15429531542953Oxymatrine for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysisXuan Zhao0Xiaolu Ye1Yuting Gu2Yijie Lou3Zhanyi Zhou4Yunxi Ji5Yunxi Ji6Daogun Xu7The First Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaThe First Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaThe First Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaThe First Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaThe First Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaThe First Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaWenling Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Taizhou, Zhejiang, ChinaBackgroundInflammatory Bowel Disease (IBD) is a chronic, idiopathic inflammatory disorder of the intestines. Oxymatrine (OMT) is a naturally active substance found in the desiccated roots of Sophora flavescens. It possesses anti-tumor, antiviral, and anti-inflammatory properties. In recent years, its therapeutic role in IBD has gradually been discovered. This review aims to explore the impact of OMT on inflammatory bowel disease by animal models.MethodsConduct a systematic search in the PubMed, Embase, Web of Science, Cochrane, and Medline databases. Using SYRCLE’s risk of bias tool to assess the bias risk and quality of the included studies. For some data presented as figures, Web Plot Digitizer 4.2 software was used to extract it. STATA 16.0 was selected for the final meta-analysis.ResultsAfter rigorous literature screening, 12 studies were included. The data analysis results indicated that the disease activity index (DAI), histopathological score (HS), interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), nuclear factor-κB (NF-κB), and myeloperoxidase (MPO) activity in the IBD animal models significantly decreased following intervention with oxymatrine. Furthermore, OMT also extended the colon length in the animal models and improved the expression level of zonula occludens-1(ZO-1) and occludin. These results suggested that OMT may improve the condition of IBD through anti-inflammatory, antioxidative stress and protecting the intestinal barrier.ConclusionMeta-analysis suggests oxymatrine positively affects IBD animal models. This provides new insights for the clinical treatment of inflammatory bowel disease.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD42024570580, identifier [CRD42024570580].https://www.frontiersin.org/articles/10.3389/fmed.2025.1542953/fulloxymatrineinflammatory bowel diseasemeta-analysisinflammationoxidative stress
spellingShingle Xuan Zhao
Xiaolu Ye
Yuting Gu
Yijie Lou
Zhanyi Zhou
Yunxi Ji
Yunxi Ji
Daogun Xu
Oxymatrine for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis
Frontiers in Medicine
oxymatrine
inflammatory bowel disease
meta-analysis
inflammation
oxidative stress
title Oxymatrine for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis
title_full Oxymatrine for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis
title_fullStr Oxymatrine for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis
title_full_unstemmed Oxymatrine for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis
title_short Oxymatrine for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis
title_sort oxymatrine for inflammatory bowel disease in preclinical studies a systematic review and meta analysis
topic oxymatrine
inflammatory bowel disease
meta-analysis
inflammation
oxidative stress
url https://www.frontiersin.org/articles/10.3389/fmed.2025.1542953/full
work_keys_str_mv AT xuanzhao oxymatrineforinflammatoryboweldiseaseinpreclinicalstudiesasystematicreviewandmetaanalysis
AT xiaoluye oxymatrineforinflammatoryboweldiseaseinpreclinicalstudiesasystematicreviewandmetaanalysis
AT yutinggu oxymatrineforinflammatoryboweldiseaseinpreclinicalstudiesasystematicreviewandmetaanalysis
AT yijielou oxymatrineforinflammatoryboweldiseaseinpreclinicalstudiesasystematicreviewandmetaanalysis
AT zhanyizhou oxymatrineforinflammatoryboweldiseaseinpreclinicalstudiesasystematicreviewandmetaanalysis
AT yunxiji oxymatrineforinflammatoryboweldiseaseinpreclinicalstudiesasystematicreviewandmetaanalysis
AT yunxiji oxymatrineforinflammatoryboweldiseaseinpreclinicalstudiesasystematicreviewandmetaanalysis
AT daogunxu oxymatrineforinflammatoryboweldiseaseinpreclinicalstudiesasystematicreviewandmetaanalysis